Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 17 | 21 | 27 | 28 | 35 |
| Accounts receivable | 6 | 4 | -65 | 147 | 22 |
| Other Working Capital | 104 | -223 | -44 | 105 | -100 |
| Other Operating Activity | -515 | -520 | -716 | -919 | 114 |
| Operating Cash Flow | $-387 | $-718 | $-797 | $-639 | $70 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -5 | -6 | -2 | 0 |
| Purchase Of Investment | -88 | -216 | -426 | -10 | -6 |
| Sale Of Investment | N/A | N/A | 633 | 1,205 | 837 |
| Other Investing Activity | 255 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $167 | $-220 | $201 | $1,193 | $830 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 486 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $486 | $0 | $0 |
| Beginning Cash Position | 1,106 | 2,044 | 2,140 | 1,579 | 674 |
| End Cash Position | 750 | 1,106 | 2,037 | 2,140 | 1,579 |
| Net Cash Flow | $-220 | $-938 | $-110 | $554 | $900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -387 | -718 | -797 | -639 | 70 |
| Capital Expenditure | N/A | -5 | -6 | -2 | 0 |
| Free Cash Flow | -387 | -723 | -803 | -641 | 70 |